Aufa, Syafiq, and Jufriady Ismy. 2026. “Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer”. Indonesian Journal of Global Health Research 8 (6):89-98. https://doi.org/10.37287/ijghr.v8i6.2572.